Document is current
Any future updates will be listed below
-
Authors
Kishi, Seiji https://orcid.org/0000-0001-6205-1661
Nagasu, Hajime https://orcid.org/0000-0003-2549-4126
Kidokoro, Kengo https://orcid.org/0000-0002-4932-0166
Kashihara, Naoki https://orcid.org/0000-0002-9487-984X
- License Information
-
More Information
Article History
Accepted: 20 September 2023
First Online: 19 October 2023
Competing interests
: N.K. has received lecture fees from Astellas, AstraZeneca, Kyowa-Kirin, Novartis and Otsuka; research funding from AstraZeneca, Daiichi Sankyo, Kyowa-Kirin, Novartis and Otsuka; and has served as an adviser for Kyowa-Kirin and Novartis. The other authors declare no conflicts of interest.
